151 related articles for article (PubMed ID: 38023819)
1. The performance and applied value of
Pan B; Zhu X; Xie Q
Am J Nucl Med Mol Imaging; 2023; 13(5):217-224. PubMed ID: 38023819
[TBL] [Abstract][Full Text] [Related]
2.
Luo Y; Cao X; Pan Q; Li J; Feng J; Li F
J Nucl Med; 2019 Dec; 60(12):1724-1729. PubMed ID: 31101745
[No Abstract] [Full Text] [Related]
3. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
4. Different extramedullary disease shown in chemokine receptor 4 targeted PET/CT with [68Ga]Ga-pentixafor in patients with Waldenström macroglobulinemia and smoldering disease.
Pan Q; Cao X; Li J; Li F; Luo Y
Nucl Med Commun; 2024 May; ():. PubMed ID: 38745523
[TBL] [Abstract][Full Text] [Related]
5.
Li X; Dong C; Ma X; Wang Y
Front Med (Lausanne); 2021; 8():668323. PubMed ID: 34046420
[No Abstract] [Full Text] [Related]
6. Chemokine Receptor CXCR4-Targeted PET/CT With 68Ga-Pentixafor Shows Superiority to 18F-FDG in a Patient With Waldenström Macroglobulinemia.
Luo Y; Pan Q; Feng J; Cao X; Li F
Clin Nucl Med; 2018 Jul; 43(7):548-550. PubMed ID: 29742593
[TBL] [Abstract][Full Text] [Related]
7. FDG PET/CT used in identifying adult-onset Still's disease in connective tissue diseases.
Zhou X; Li Y; Wang Q
Clin Rheumatol; 2020 Sep; 39(9):2735-2742. PubMed ID: 32180040
[TBL] [Abstract][Full Text] [Related]
8. PET-CT for Evaluation of Spleen and Liver 18F-FDG Diffuse Uptake Without Lymph Node Enlargement in Lymphoma.
Rao L; Wang X; Zong Z; Chen Z; Shi X; Yi C; Zhang X; Yang Z
Medicine (Baltimore); 2016 May; 95(20):e3750. PubMed ID: 27196500
[TBL] [Abstract][Full Text] [Related]
9. 18F-FDG PET/CT in patients with adult-onset Still's disease.
Dong MJ; Wang CQ; Zhao K; Wang GL; Sun ML; Liu ZF; Xu L
Clin Rheumatol; 2015 Dec; 34(12):2047-56. PubMed ID: 25711875
[TBL] [Abstract][Full Text] [Related]
10. [PET-CT Manifestation and Clinical Analysis of Waldenstrom Macroglobulinemia].
Ding CY; Liu HY; Guo Z; Li TN
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Dec; 24(6):1782-1786. PubMed ID: 28024494
[TBL] [Abstract][Full Text] [Related]
11. (18)F-FDG and (18)F-FLT PET/CT imaging in the characterization of mediastinal lymph nodes.
Rayamajhi SJ; Mittal BR; Maturu VN; Agarwal R; Bal A; Dey P; Shukla J; Gupta D
Ann Nucl Med; 2016 Apr; 30(3):207-16. PubMed ID: 26661845
[TBL] [Abstract][Full Text] [Related]
12. [Value of Pretherapeutic
Ding CY; Liu HY; Guo Z; Li TN
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):438-443. PubMed ID: 28446289
[TBL] [Abstract][Full Text] [Related]
13. Lymphoplasmacytic lymphoma relapse presenting as isolated multifocal subcutaneous adipose tissue infiltrates on 18F-FDG PET/CT.
Anžej Doma S; Doma A
Acta Radiol Open; 2023 May; 12(5):20584601231173052. PubMed ID: 37179796
[TBL] [Abstract][Full Text] [Related]
14. [Value of
Pan B; Wang SC; Zhan FL; Ni M; Liu X; Zhang YF; Xie Q; Xie JK
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Feb; 30(1):189-194. PubMed ID: 35123625
[TBL] [Abstract][Full Text] [Related]
15. Usefulness and pitfalls of F-18-FDG PET/CT for diagnosing extramedullary acute leukemia.
Zhou WL; Wu HB; Wang LJ; Tian Y; Dong Y; Wang QS
Eur J Radiol; 2016 Jan; 85(1):205-210. PubMed ID: 26724667
[TBL] [Abstract][Full Text] [Related]
16. Chemokine Receptor 4-Targeted 68Ga-Pentixafor PET/CT in Response Assessment of Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma: Comparison to 18F-FDG PET/CT.
Pan Q; Cao X; Luo Y; Li J; Li F
Clin Nucl Med; 2021 Sep; 46(9):732-737. PubMed ID: 34172595
[TBL] [Abstract][Full Text] [Related]
17. The role of 18F-FDG PET/CT imaging in Waldenstrom macroglobulinemia.
Banwait R; O'Regan K; Campigotto F; Harris B; Yarar D; Bagshaw M; Leleu X; Leduc R; Ramaiya N; Weller E; Ghobrial IM
Am J Hematol; 2011 Jul; 86(7):567-72. PubMed ID: 21681781
[TBL] [Abstract][Full Text] [Related]
18. A predicting model of bone marrow malignant infiltration in
Zhou M; Chen Y; Liu J; Huang G
J Cancer; 2018; 9(10):1737-1744. PubMed ID: 29805699
[No Abstract] [Full Text] [Related]
19. In newly diagnosed diffuse large B-cell lymphoma, determination of bone marrow involvement with 18F-FDG PET/CT provides better diagnostic performance and prognostic stratification than does biopsy.
Berthet L; Cochet A; Kanoun S; Berriolo-Riedinger A; Humbert O; Toubeau M; Dygai-Cochet I; Legouge C; Casasnovas O; Brunotte F
J Nucl Med; 2013 Aug; 54(8):1244-50. PubMed ID: 23674577
[TBL] [Abstract][Full Text] [Related]
20. Baseline 18 F-FDG PET/CT May Portend the Prognosis of Patients With Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma After First-Line Treatment.
Pan Q; Cao X; Luo Y; Li J; Li F
Clin Nucl Med; 2022 Nov; 47(11):954-960. PubMed ID: 35961637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]